Emerging HDL-based therapies for atherothrombotic vascular disease
PK Shah - Current Treatment Options in Cardiovascular Medicine, 2007 - Springer
Opinion statement Statin therapy has been a significant advance in the management of
dyslipidemia and atherothrombotic cardiovascular disease with a resultant 30% to 40 …
dyslipidemia and atherothrombotic cardiovascular disease with a resultant 30% to 40 …
Emerging HDL-based therapies for atherothrombotic vascular disease
PK Shah - Current Treatment Options in Cardiovascular Medicine, 2007 - infona.pl
Opinion statement Statin therapy has been a significant advance in the management of
dyslipidemia and atherothrombotic cardiovascular disease with a resultant 30% to 40 …
dyslipidemia and atherothrombotic cardiovascular disease with a resultant 30% to 40 …
Emerging HDL-based therapies for atherothrombotic vascular disease.
PK Shah - Current Treatment Options in Cardiovascular Medicine, 2007 - europepmc.org
Statin therapy has been a significant advance in the management of dyslipidemia and
atherothrombotic cardiovascular disease with a resultant 30% to 40% reduction in …
atherothrombotic cardiovascular disease with a resultant 30% to 40% reduction in …
Emerging HDL-based therapies for atherothrombotic vascular disease
PK Shah - Current treatment options in cardiovascular …, 2007 - pubmed.ncbi.nlm.nih.gov
Statin therapy has been a significant advance in the management of dyslipidemia and
atherothrombotic cardiovascular disease with a resultant 30% to 40% reduction in …
atherothrombotic cardiovascular disease with a resultant 30% to 40% reduction in …